DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
YTTRIUM Y 90 CLIVATUZUMAB TETRAXETAN
Search structure
Synonyms:
90HY-PAM4
90Y-HPAM4
90Y-HPAMA4
Hpam4-cide
HPAM-4-DOTA
HPAM4-DOTA
HPAM-DOTA HY-PAM4
IMMU-107
S9S0HY-PAM4
Yttrium (90y) clivatuzumab tetraxetan
Yttrium y 90 clivatuzumab tetraxetan
Status:
Phase 3
Entry Type:
Antibody
Molecule Category:
UNKNOWN
Pharmacology
Action
Mechanism of Action
Reference
BINDING AGENT
Mucin-5AC binding agent
PubMed
Indications
Mesh Heading
Maximum Phase
Mesh ID
Reference
Pancreatic Neoplasms
3
D010190
ClinicalTrials
Cross References
Resources
Reference
ChEMBL
CHEMBL2108708
CONTENTS
Structure
Indications
Cross References
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70